# Verisk Analytics, Inc. (VRSK)

> Source: Nexqual · https://nexqual.com/VRSK · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Verisk Analytics, Inc. (VRSK), nexqual.com/VRSK" · informational, not investment advice.

**Price:** USD 203.33 (+5.71% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 192.34 · day 195.58–203.47 · 52w 155.94–237.85 · market cap $26.5B · NMS

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $3.14B, net income $886M (28.2% margin), free cash flow $1.24B (SEC filings).
- Valuation: P/E 29.9x (avg 44.3x at the last 3 fiscal year-ends), EV/EBITDA 18.6x, net debt $3.92B.
- 5 of 80 tracked superinvestors hold VRSK (13F, Q2 2026): 0 new, 2 added, 2 reduced, 1 unchanged.
- Analysts: Buy (mean 2.21 on a 1–5 scale) (19 analysts), mean target USD 226.47 (range 195–260).
- Total return with dividends: 1Y -12.5% vs S&P 500 +14.9%; 5Y -1.6% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD 1.92, revenue estimate $806M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $2.46B | $2.50B | $2.68B | $2.88B | $3.07B | $3.14B |
| Gross profit | $1.61B | $1.67B | $1.80B | $1.98B | $2.15B | — |
| Operating income | $911M | $1.41B | $1.13B | $1.25B | $1.34B | $1.38B |
| Net income | $666M | $954M | $615M | $958M | $908M | $886M |
| EPS (diluted) | $4.08 | $6.00 | $4.17 | $6.71 | $6.48 | — |
| Free cash flow | $887M | $784M | $831M | $920M | $1.19B | $1.24B |
| Gross margin | 65.3% | 67.0% | 67.3% | 68.7% | 69.9% | — |
| Operating margin | 37.0% | 56.3% | 42.2% | 43.5% | 43.7% | 43.9% |
| Net margin | 27.1% | 38.2% | 22.9% | 33.3% | 29.6% | 28.2% |
| Revenue growth | +8.5% | +1.4% | +7.4% | +7.5% | +6.6% | — |
| Cash + short-term investments | $112M | $113M | $303M | $291M | $2.18B | — |
| Total debt | $4.29B | $5.14B | $2.90B | $3.61B | $6.28B | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 29.9x · P/S 8.4x · EV/EBITDA 18.6x · EV/Sales 9.7x · P/FCF 21.4x · FCF yield 4.67% · Earnings yield 3.35% · Dividend yield (paid, TTM) 0.97% · Buyback yield (TTM) 7.16% · Net debt $3.92B · EV $30.4B
P/E at fiscal year-ends: Dec 2025 34.5x, Dec 2024 41.1x, Dec 2023 57.3x.

## Superinvestors (SEC 13F-HR, Q2 2026)
5 of 80 tracked investors hold VRSK. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Jensen Investment Management |  | 1.65% | $68.1M | Reduced -21.3% |
| Torray Funds |  | 0.59% | $4.4M | Reduced -0.3% |
| Thomas Gayner | Markel Group | 0.21% | $28.0M | Unchanged |
| Lindsell Train |  | 0.06% | $1.7M | Added +13.1% |
| Yacktman Asset Management |  | 0.05% | $3.8M | Added +43.4% |

## Analysts
Consensus Buy (mean 2.21 on a 1–5 scale), 19 analysts; mean target USD 226.47 (low 195, high 260).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-13 | BMO Capital | Target lowered | Outperform | $248 → $217 |
| 2026-10-13 | Morgan Stanley | Target lowered | Equal-Weight | $235 → $215 |
| 2026-09-08 | Barclays | Target lowered | Overweight | $275 → $225 |
| 2026-07-30 | UBS | Target raised | Neutral | $220 → $235 |
| 2026-07-30 | Evercore ISI Group | Target raised | In-Line | $222 → $223 |
| 2026-07-30 | Wells Fargo | Target raised | Overweight | $240 → $260 |
| 2026-07-23 | Jefferies | Upgrade | Hold → Buy | $192 → $235 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | -12.5% | -1.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -12.6% | -0.3% |
| Volatility (annualized) | 36.8% | 26.7% |
| Max drawdown | -32.9% (Oct 2025→May 2026) | -48.7% (Jun 2025→May 2026) |

## Peers (Consulting Services)
EFX (Equifax, Inc.) USD 187.14 +6.59% · BAH (Booz Allen Hamilton Holding Cor) USD 78.57 +4.70% · FCN (FTI Consulting, Inc.) USD 157.59 +5.50% · HURN (Huron Consulting Group Inc.) USD 193.35 +5.47% · ICFI (ICF International, Inc.) USD 93.33 +3.76% · CRAI (CRA International,Inc.) USD 200.94 +9.59%

## More
Full page: https://nexqual.com/VRSK · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Revenue by product line (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Underwriting | $569.1M | 70.6% | +3.5% |
| Claims | $237.2M | 29.4% | +6.4% |
| Total revenue | $806.3M | 100% | — |

## Revenue by region (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| United States | $651.3M | 80.8% | +3.8% |
| Other Countries | $88.7M | 11.0% | +8.2% |
| United Kingdom | $66.3M | 8.2% | +5.1% |
| Total revenue | $806.3M | 100% | — |

## Customer concentration

Period ended 2025-12-31: 3% of revenue from unnamed direct customers (10-K, filed 2026-02-18).

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $1.92 | $1.95 | -1.2% | $806.2M | 15 |
| Next quarter (ends 2026-12-31) | $1.97 | $1.98 | -0.2% | $824.9M | 15 |
| Current fiscal year (ends 2026-12-31) | $7.70 | $7.67 | +0.5% | $3.22B | 19 |
| Next fiscal year (ends 2027-12-31) | $8.70 | $8.68 | +0.2% | $3.44B | 19 |